Abstract
In recent decades, prostate cancer incidence rates have risen significantly, underscoring the urgent need for advances in diagnostic and therapeutic strategies. More recently, research efforts have increasingly focused on the development of radioligands targeting PSMA, a molecule highly expressed in prostate tumor cells, with the aim of enabling more accurate diagnoses and effective thera…